Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

1,730.00p
   
  • Change Today:
    -26.00p
  • 52 Week High: 2,792.00
  • 52 Week Low: 1,637.00
  • Currency: UK Pounds
  • Shares Issued: 66.03m
  • Volume: 13,896
  • Market Cap: £1,142.35m
  • RiskGrade: 128

Genus profits dented by PIC China challenges

By Michele Maatouk

Date: Thursday 08 Sep 2022

LONDON (ShareCast) - (Sharecast News) - Animal genetics company Genus posted a drop in full-year profit on Thursday as it took a hit from challenging market conditions in its PIC China business.
In the year to 30 June, pre-tax profit fell 16% to £71.5m on revenues of £593.4m, up 3% on the previous year.

Genus hailed a "robust" performance across the business but said that the PIC China business was a drag. Excluding PIC, group adjusted pre-tax profit rose 25% at constant currency and revenues were up 7%.

Genus said adjusted operating profit in the PIC China segment fell 13%. China pig prices averaged 14.6 RMB/kg in the year, down 50% on the previous year. However, since June these have recovered to over 21 RMB/kg, which exceeds the cost of production for most producers.

Chief executive Stephen Wilson said: "The group performed robustly, although challenging market conditions in China porcine impacted the performance of PIC.

"Bovine producers faced more challenging conditions in the second half of the year, as a result of significantly increased input costs and the Ukraine war. However, ABS continued to grow volumes and expand margins, driven by the success of Sexcel (including expansion of sales through our third party IntelliGen business), as well as strong growth in sales of our proprietary NuEra beef genetics across all regions."

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Genus Market Data

Currency UK Pounds
Share Price 1,730.00p
Change Today -26.00p
% Change -1.48 %
52 Week High 2,792.00
52 Week Low 1,637.00
Volume 13,896
Shares Issued 66.03m
Market Cap £1,142.35m
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
95.64% below the market average95.64% below the market average95.64% below the market average95.64% below the market average95.64% below the market average
96.23% below the sector average96.23% below the sector average96.23% below the sector average96.23% below the sector average96.23% below the sector average
Price Trend
58.97% below the market average58.97% below the market average58.97% below the market average58.97% below the market average58.97% below the market average
26.32% above the sector average26.32% above the sector average26.32% above the sector average26.32% above the sector average26.32% above the sector average
Income
85.96% below the market average85.96% below the market average85.96% below the market average85.96% below the market average85.96% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Growth
69.65% below the market average69.65% below the market average69.65% below the market average69.65% below the market average69.65% below the market average
56.76% below the sector average56.76% below the sector average56.76% below the sector average56.76% below the sector average56.76% below the sector average

What The Brokers Say

Strong Buy 5
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 7
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Interim Final
Ex-Div 29-Feb-24 09-Nov-23
Paid 28-Mar-24 08-Dec-23
Amount 10.30p 21.70p

Trades for 19-Apr-2024

Time Volume / Share Price
13:57 137 @ 1,730.00p
13:57 143 @ 1,730.00p
13:57 205 @ 1,730.00p
13:57 3 @ 1,730.00p
13:57 12 @ 1,730.00p

Genus Key Personnel

CFO Alison Henriksen
CEO Jorgen Kokke

Top of Page